BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 16476851)

  • 21. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; LombraƱa A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice.
    Buckley MG; Marcus NJ; Yacoub MH
    Clin Sci (Lond); 1999 Dec; 97(6):689-95. PubMed ID: 10585896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men.
    Ohba H; Takada H; Musha H; Nagashima J; Mori N; Awaya T; Omiya K; Murayama M
    Am Heart J; 2001 May; 141(5):751-8. PubMed ID: 11320362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism.
    Kiely DG; Kennedy NS; Pirzada O; Batchelor SA; Struthers AD; Lipworth BJ
    Respir Med; 2005 Oct; 99(10):1286-91. PubMed ID: 16099151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
    Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ
    Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
    Ding LG; Hua W; Zhang S; Chu JM; Chen KP; Wang Y; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Mar; 122(6):617-21. PubMed ID: 19323922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional sampling and the effects of experimental heart failure in sheep: differential responses in A, B and C-type natriuretic peptides.
    Charles CJ; Prickett TC; Espiner EA; Rademaker MT; Richards AM; Yandle TG
    Peptides; 2006 Jan; 27(1):62-8. PubMed ID: 16095755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Atrial and B-type natriuretic peptides: from the research lab to clinical practice].
    Boomsma F; van den Meiracker AH
    Ned Tijdschr Geneeskd; 2003 Apr; 147(16):743-8. PubMed ID: 12731463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation.
    Engelmann MD; Niemann L; Kanstrup IL; Skagen K; Godtfredsen J
    Int J Cardiol; 2005 Oct; 105(1):31-9. PubMed ID: 16207542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical implications of current natriuretic peptide research.
    Sagnella GA
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):304-15. PubMed ID: 11967816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction on metabolic clearance between A-type and B-type natriuretic peptides in patients with heart failure.
    Yoshimura M; Mizuno Y; Harada E; Nakayama M; Shimasaki Y; Ito T; Nakamura S; Soejima H; Miyamoto S; Takazoe K; Ogawa H; Kugiyama K; Saito Y; Nakao K; Yasue H
    Metabolism; 2000 Sep; 49(9):1228-33. PubMed ID: 11016910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?
    de Groote P; Soudan B; Lamblin N; Rouaix-Emery N; Mc Fadden E; Meurice T; Mouquet F; Bauters C
    Am Heart J; 2004 Aug; 148(2):349-55. PubMed ID: 15309008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial.
    Olsson LG; Swedberg K; Cleland JG; Spark PA; Komajda M; Metra M; Torp-Pedersen C; Remme WJ; Scherhag A; Poole-Wilson P;
    Eur J Heart Fail; 2007 Aug; 9(8):795-801. PubMed ID: 17693380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.